Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026)
Soleno Therapeutics (SLNO) reported Prepaid Assets of $6.3 million for Q1 2026, down 66.62% year-over-year from $19.0 million in Q1 2025, and down 10.97% on a QoQ basis from $7.1 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Prepaid Assets data on file, last reported at $6.3 million in Q1 2026.
- Quarterly Prepaid Assets fell 66.62% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 66.62% YoY) and the FY2025 annual result came in at $7.1 million, up 189.97% from the prior year.
- Prepaid Assets eased to $6.3 million in Q1 2026 per SLNO's latest filing, from $7.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $19.0 million in Q1 2025 and bottomed at $821000.0 in Q3 2022.
- The 5-year median for Prepaid Assets is $1.4 million (2024), against an average of $3.2 million.
- The widest annual swing landed in 2025, when Prepaid Assets soared 1088.28%; it then tumbled 66.62% in 2026.
- Tracing SLNO's Prepaid Assets over 5 years: stood at $1.0 million in 2022, then surged by 60.48% to $1.7 million in 2023, then jumped by 46.21% to $2.5 million in 2024, then jumped by 189.97% to $7.1 million in 2025, then decreased by 10.97% to $6.3 million in 2026.
- Per Business Quant, the three latest SLNO Prepaid Assets figures stand at $6.3 million (Q1 2026), $7.1 million (Q4 2025), and $3.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.33 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 18.97 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 821,000.00 |
| Jun 30, 2022 | 824,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 702,000.00 |
| Jun 30, 2021 | 948,000.00 |
| Mar 31, 2021 | 921,000.00 |
| Dec 31, 2020 | 1.02 Mn |
| Sep 30, 2020 | 348,000.00 |
| Jun 30, 2020 | 505,000.00 |
| Mar 31, 2020 | 572,000.00 |
| Dec 31, 2019 | 411,000.00 |
| Sep 30, 2019 | 375,000.00 |
| Jun 30, 2019 | 471,000.00 |
| Mar 31, 2019 | 603,000.00 |
| Dec 31, 2018 | 529,000.00 |
| Sep 30, 2018 | 327,000.00 |
| Jun 30, 2018 | 248,000.00 |
| Mar 31, 2018 | 423,000.00 |
| Dec 31, 2017 | 343,000.00 |
| Sep 30, 2017 | 145,000.00 |
| Jun 30, 2017 | 246,000.00 |
| Mar 31, 2017 | 261,000.00 |
| Dec 31, 2016 | 246,570.00 |
| Sep 30, 2016 | 217,000.00 |
| Jun 30, 2016 | 157,000.00 |
| Mar 31, 2016 | 216,000.00 |
| Dec 31, 2015 | 167,642.00 |
| Sep 30, 2015 | 225,000.00 |
| Jun 30, 2015 | 311,000.00 |
| Mar 31, 2015 | 260,000.00 |
| Dec 31, 2014 | 252,272.00 |
| Sep 30, 2014 | 186,000.00 |
| Dec 31, 2013 | 85,149.00 |